ClearPoint Neuro, Inc.
CLPT· Nasdaq
Source filing unavailable
| Metric | Q3 2012 | Q3 2011 |
|---|---|---|
| Revenue | $1.13M | $1.15M |
| Net Income | -$2.76M | -$2.14M |
| EPS Diluted | -$0.06 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR